Its lead candidate, pemvidutide, is being evaluated in multiple indications, including metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder, and alcohol-associated liver disease
The primary evidence-based treatment for fatty liver disease is lifestyle modification, including weight loss of at least 710% through dietary changes and increased physical activity
Compared to Western diet, MedDiet promotes reduced overall fat intake, with primary intake of healthy fats like olive oil, resulting in lowered production of secondary BAs, favoring reduced inflammation and a decreased risk of obesity
Many patients in medically supervised programs not only lose weight but also see improvements in related health issues, such as type 2 diabetes, high blood pressure, elevated cholesterol, and sleep apnea